Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation
Marek Malík
Drug Safety (2016) Vol. 39, Iss. 7, pp. 647-659
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Katja Zeppenfeld, Jacob Tfelt‐Hansen, Marta Riva, et al.
European Heart Journal (2022) Vol. 43, Iss. 40, pp. 3997-4126
Closed Access | Times Cited: 1701
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
James E. Tisdale, Mina K. Chung, Kristen Bova Campbell, et al.
Circulation (2020) Vol. 142, Iss. 15
Open Access | Times Cited: 231
QT Assessment in Early Drug Development: The Long and the Short of It
Robert M. Lester, Sabina Paglialunga, Ian Johnson
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1324-1324
Open Access | Times Cited: 64
Role of the rabbit whole-heart model for electrophysiologic safety pharmacology of non-cardiovascular drugs
Christian Ellermann, Julian Wolfes, Lars Eckardt, et al.
EP Europace (2020) Vol. 23, Iss. 6, pp. 828-836
Closed Access | Times Cited: 28
Implantable cardioverter defibrillator therapy in repaired tetralogy of Fallot after pulmonary valve replacement: Implications for the mechanism of ventricular arrhythmia
Shuenn‐Nan Chiu, Shu‐Chien Huang, Jou‐Kou Wang, et al.
International Journal of Cardiology (2017) Vol. 249, pp. 156-160
Closed Access | Times Cited: 20
A Phase 1 Clinical Study Evaluating the Effects of Cenobamate on the QT Interval
Börje Darpö, Philip T. Sager, Hongqi Xue, et al.
Clinical Pharmacology in Drug Development (2022) Vol. 11, Iss. 4, pp. 523-534
Closed Access | Times Cited: 10
Analysis of an ECG Record Database Reveals QT Interval Prolongation Potential of Famotidine in a Large Korean Population
Jaesuk Yun, Eun Hwangbo, Jongpill Lee, et al.
Cardiovascular Toxicology (2014) Vol. 15, Iss. 2, pp. 197-202
Closed Access | Times Cited: 18
Recent developments in the science of proarrhythmic cardiac safety of new drugs
J. Rick Turner, Dilip R. Karnad, Christopher H. Cabell, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2016) Vol. 3, Iss. 2, pp. 118-124
Open Access | Times Cited: 16
A molecular pathway analysis informs the genetic risk for arrhythmias during antipsychotic treatment
Antonio Drago, Ellen Kure Fischer
International Clinical Psychopharmacology (2017) Vol. 33, Iss. 1, pp. 1-14
Closed Access | Times Cited: 14
Transgenic Rabbit Models in Proarrhythmia Research
István Baczkó, Tibor Hornyik, Michael Brunner, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 10
Comprehensive in vitro pro‐arrhythmic assays demonstrate that omecamtiv mecarbil has low pro‐arrhythmic risk
Yusheng Qu, BaoXi Gao, Ziva Arimura, et al.
Clinical and Translational Science (2021) Vol. 14, Iss. 4, pp. 1600-1610
Open Access | Times Cited: 9
Therapeutic effects of a taurine-magnesium coordination compound on experimental models of type 2 short QT syndrome
Meng-Yao An, Kai Sun, Yan Li, et al.
Acta Pharmacologica Sinica (2017) Vol. 39, Iss. 3, pp. 382-392
Open Access | Times Cited: 8
Genetic Variants as Sudden-Death Risk Markers in Inherited Arrhythmogenic Syndromes: Personalized Genetic Interpretation
Óscar Campuzano, Geòrgia Sarquella-Brugada, Elena Arbelo, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1866-1866
Open Access | Times Cited: 7
Clinical benefits of magnesium sulfate in management of acute organophosphorus poisoning
SamahF Ibrahim, UsamaM Elbarrany, MohammedA Mohamed, et al.
The Saudi Journal of Forensic Medicine and Sciences (2018) Vol. 1, Iss. 2, pp. 30-30
Closed Access | Times Cited: 6
hERG agonists pose challenges to web-based machine learning methods for prediction of drug-hERG channel interaction
Aziza El Harchi, Jules C. Hancox
Journal of Pharmacological and Toxicological Methods (2023) Vol. 123, pp. 107293-107293
Open Access | Times Cited: 2
Drug-induced arrhythmias
М. В. Леонова
Meditsinskiy sovet = Medical Council (2021), Iss. 21, pp. 26-40
Open Access | Times Cited: 5
Dextropropoxyphene effects on QTc-interval prolongation: Frequency and characteristics in relation to plasma levels
Guillermo Alberto Keller, Cecilia Villa Etchegoyen, Nicolás Fernández, et al.
Journal of Opioid Management (2018) Vol. 14, Iss. 5, pp. 335-344
Open Access | Times Cited: 3
Long- und Short-QT-Syndrome
Boris Rudic, Martin Borggrefe
Springer Reference Medizin (2024), pp. 1-10
Closed Access
Application of k-Nearest Neighbors Method for Drug Concentration and Cardiotoxicity Classification Using Extracellular Field Potentials and Reconstructed Action Potentials of Cardiac Cells
Mukhailo Oleksandrovych Shpotak, Н. Г. Иванушкина
Microsystems Electronics and Acoustics (2024) Vol. 29, Iss. 1
Open Access
QT shortening: a proarrhythmic safety surrogate measure or an inappropriate indicator of it?
Amy Tanti, Benjamin Micallef, Janis Vella Szijj, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 9, pp. 1473-1483
Closed Access | Times Cited: 2
The Comprehensive In Vitro Proarrhythmia Assay Initiative
J. Rick Turner, Dilip R. Karnad, Snehal Kothari
Springer eBooks (2016), pp. 181-197
Closed Access | Times Cited: 1
Cardiovascular Structure, Function, and Pathophysiology
J. Rick Turner, Dilip R. Karnad, Snehal Kothari
Springer eBooks (2016), pp. 51-70
Closed Access | Times Cited: 1
Antiepileptic rufinamide and QTc interval shortening in a patient with long QT syndrome: case report
Tapas Mondal, Kristen Sullivan, Syam Divakaramenon, et al.
European Heart Journal - Case Reports (2020) Vol. 4, Iss. 6, pp. 1-4
Open Access | Times Cited: 1
Experimental evidence for proarrhythmic effects of nonsteroidal anti‐inflammatory drugs in a sensitive whole‐heart model
Julian Wolfes, Christian Ellermann, Svenja Bäumer, et al.
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 130, Iss. 1, pp. 103-109
Open Access | Times Cited: 1
QT interval prolongation, torsades de pointes and psychotropic medication
Theocharis Chr. Kyziridis
Hellenic Journal of Nursing Science (2022), pp. 43-59
Open Access
Page 1 - Next Page

Scroll to top